![]() |
|
|
This article has been cited by other articles:
![]() |
W. Liu, X. Shen, Y. Yang, X. Yin, J. Xie, J. Yan, J. Jiang, W. Liu, H. Wang, M. Sun, et al. Trihydrophobin 1 Is a New Negative Regulator of A-Raf Kinase J. Biol. Chem., March 12, 2004; 279(11): 10167 - 10175. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Khurana, J. F. Martin, and I. Zachary Gene Therapy for Cardiovascular Disease: A Case for Cautious Optimism Hypertension, November 1, 2001; 38(5): 1210 - 1216. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Kibbe, T. R. Billiar, and E. Tzeng Gene Therapy for Restenosis Circ. Res., April 28, 2000; 86(8): 829 - 833. [Full Text] [PDF] |
||||
![]() |
J. Wrzesinski, M. Legiewicz, and J. Ciesiolka Mapping of accessible sites for oligonucleotide hybridization on hepatitis delta virus ribozymes Nucleic Acids Res., April 15, 2000; 28(8): 1785 - 1793. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Butler, R. M. Crooke, M. J. Graham, K. M. Lemonidis, M. Lougheed, S. F. Murray, D. Witchell, U. Steinbrecher, and C. F. Bennett Phosphorothioate Oligodeoxynucleotides Distribute Similarly in Class A Scavenger Receptor Knockout and Wild-Type Mice J. Pharmacol. Exp. Ther., February 1, 2000; 292(2): 489 - 496. [Abstract] [Full Text] |
||||
![]() |
G. Schmajuk, H. Sierakowska, and R. Kole Antisense Oligonucleotides with Different Backbones. MODIFICATION OF SPLICING PATHWAYS AND EFFICACY OF UPTAKE J. Biol. Chem., July 30, 1999; 274(31): 21783 - 21789. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Schumacher, C. L. Cioffi, H. Sharif, W. Haston, B. P. Monia, and L. Wennogle Exposure of Human Vascular Smooth Muscle Cells to Raf-1 Antisense Oligodeoxynucleotides: Cellular Responses and Pharmacodynamic Implications Mol. Pharmacol., January 1, 1998; 53(1): 97 - 104. [Abstract] [Full Text] |
||||